Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Dengue fever vaccine looks very promising

The vaccine Tetravalent is manufactured by drug company Sanofi who say it will be ready to be submitted for approval by the year 2012.

7 Nov 2007

Researchers neutralise the HIV virus

With the latest advances in treatment, doctors have discovered that they can successfully neutralise the HIV virus.

6 Nov 2007

Improving hospital safety rating tools

In a bid to clean up misleading institutional safety comparisons and go further to fix safety problems, Johns Hopkins experts are proposing standard guidelines to be used as hospital safety rating tools.

6 Nov 2007

MRSA prevalent in Canadian pig farms and pig farmers

A new study published in Veterinary Microbiology found methicillin-resistant Staphylococcus aureus (MRSA) prevalent in Canadian pig farms and pig farmers, pointing to animal agriculture as a source of the deadly bacteria.

6 Nov 2007

Selective resequencing provides low-cost method for interpreting human genome

Cold Spring Harbor, NY Scientists at Cold Spring Harbor Laboratory (CSHL) have developed a new means of extracting and interpreting data from the human genome that is more powerful and more economical than methods currently employed.

6 Nov 2007

Urban kids with asthma need more frequent check-ups

Because even mild asthma among young inner-city children appears to be more unpredictable than ever, four or more check-ups a year after diagnosis is a wise move as a hedge against dangerous flare-ups of wheezing and trips to the emergency room, according to a study from the Johns Hopkins Children's Center.

6 Nov 2007

Microtek Medical introduces disposable stethoscope covers

Microtek Medical Holdings Inc. has announced the release of StethoClean, a new device that offers clean, disposable stethoscope covers to protect each patient from germs and infectious disease.

6 Nov 2007

Immtech receives $5.1 million to tackle trypanosomiasis and leishmania

Immtech Pharmaceuticals, Inc. has announced that it has received $5.1 million from a scientific consortium led by the University of North Carolina at Chapel Hill (UNC), which received funds from The Bill & Melinda Gates Foundation, to develop drugs for fighting African sleeping sickness (trypanosomiasis) and leishmania.

6 Nov 2007

Blood pressure more of a problem in winter

According to the latest research from the U.S. high blood pressure may be more difficult to control in winter.

6 Nov 2007

Common blood pressure medications ACEIs and ARBs provide equal control

Two common classes of blood pressure medications – angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – are equally effective at controlling high blood pressure, according to a report released by the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services.

5 Nov 2007

Cutting-edge method that captures cell growth and activity

This month's issue of Cold Spring Harbor Protocols features a cutting-edge method that provides a snapshot of growth and activity patterns in mixed populations of cells. The protocol is freely accessible online.

2 Nov 2007

Children with Asperger syndrome have a high prevalence of some sleep disorders

The first known attempt to evaluate the sleep patterns of children with Asperper Syndrome (AS), taking into account sleep architecture and the cyclic alternating pattern (CAP), finds that children with AS have a high prevalence of some sleep disorders and mainly problems related to initiating sleep and sleep restlessness together with morning problems and daytime sleepiness, according to a study published in the November 1 issue of the journal SLEEP.

2 Nov 2007

Barack Obama pledges to increase spending on global HIV/AIDS to $50 billion

Barack Obama today stepped ahead of all other candidates for President in one of the most critical areas of foreign policy, the effort to eradicate extreme poverty.

1 Nov 2007

Heart attacks/pneumonia falls short of national goals

Emergency departments across the nation are failing to meet national goals in treating many heart attack and pneumonia patients, according to a study by Johns Hopkins researchers published in the October issue of Academic Emergency Medicine.

1 Nov 2007

Significant improvement over current test for human papillomavirus

Iowa State University researchers have developed a technology that detects a single molecule of the virus associated with cervical cancer in women.

31 Oct 2007

Myths and misunderstandings about bipolar disorder

Portrayals of bipolar disorder seem to be cropping up everywhere -- in the news, in movies, and on television.

31 Oct 2007

Cancers successfully treated by targeting the viruses that cause them

Researchers at the Albert Einstein College of Medicine of Yeshiva University have shown for the first time that cancers can be successfully treated by targeting the viruses that cause them.

31 Oct 2007

Children would need different medical care in wake of dirty bomb

If terrorists were to attack with a dirty bomb, medical authorities should be prepared to treat children differently than adults because their developing bodies would absorb and respond to the radiation exposure in distinct ways, according to a new study from the University of Rochester Medical Center.

31 Oct 2007

Preventing lung scarring may extend lives of lung cancer patients

Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients – pulmonary fibrosis (scarring of the lungs), thereby extending patients' lives and improving their quality of life, according to a study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

HIV vaccine trial volunteers asked to undergo testing to determine whether they are at increased risk of HIV

Researchers have asked more than 3,000 people who participated in a trial of Merck's experimental HIV vaccine that was halted last month to undergo additional testing to determine if they are at an increased risk of HIV, Reuters reports (Fox, Reuters, 10/25).

29 Oct 2007